Title
Context-Dependent Immunogenicity of an S206G-Substituted H-2DB-Restricted Simian Virus 40 Large T Antigen Epitope I Variant
Document Type
Article
Publication Date
1999
Abstract
SV40 large tumor Ag (Tag) contains four H-2b-restricted (I, II/III, IV, and V) CTL epitopes. A hierarchy exists among these CTL epitopes. CTL directed against epitopes I, II/III, and IV are readily detected following immunization of H-2b mice with SV40, Tag-transformed syngeneic cells, or a vaccinia recombinant that expresses full-length Tag, while epitope V-specific CTL are not. The mechanisms that define this hierarchy remain unknown. Initial studies have shown that the locations of epitopes I and V within SV40 Tag do not determine the immunological potencies of these epitopes. Like the wild-type Tag, derivatives in which the locations of epitopes I and V were precisely reversed within Tag failed to induce epitope V-specific CTL, but did induce epitope I-specific CTL. The use of an S206G-substituted epitope I variant (GAINNYAQKL) revealed that the S206G variant sequence induced CTL when located within the native epitope I context, but failed to do so when located within the epitope V context of Tag. Mutagenesis of residues adjacent to the S206G-substituted epitope I variant revealed that the identity of the residue flanking the amino terminus of the S206G variant was critical when it resided within the epitope V location, but not within the epitope I location. These results demonstrate that effects imposed by both regional context and adjacent residues can modulate immunogenicity, but that the relative importance of such effects varies in an epitope-dependent manner.
Recommended Citation
Mylin, Larry M., "Context-Dependent Immunogenicity of an S206G-Substituted H-2DB-Restricted Simian Virus 40 Large T Antigen Epitope I Variant" (1999). Biology Educator Scholarship. 23.
https://mosaic.messiah.edu/bio_ed/23
Comments
Mylin L. M. (1999). Context-dependent immunogenicity of an S206G-substituted H-2Db-restricted simian virus 40 large T antigen epitope I variant. Journal of immunology (Baltimore, Md. : 1950), 162(4), 2171–2179.